Lonza BioWhittaker UltraDoma PF protein-free hybridoma medium

Thursday, 11 November, 2010 | Supplied by: Capsugel Australia Pty Ltd

BioWhittaker UltraDoma with L-glutamine is a protein-free formulation designed for the cultivation of murine, human and chimeric hybridomas, myeloma growth and monoclonal antibody production.

The completely defined medium with HEPES buffer and L-glutamine does not contain peptides or tissue extracts.

It significantly speeds and simplifies downstream processing and purification as all proteins present in a given cell culture supernatant are produced by the cells.

Available as 1x liquid or a powder, it is designed for lab experiments right up to industrial-scale applications.

Online: lonzabioscience.com.au
Phone: 1300 657508

Content from other channels on our network

Government announces $1.1bn for cleaner fuel production

ABB Robotics invests in vision AI company

Green Gravity and Wollongong City sign MOU for clean energy innovation

Haigh's Chocolates opens new SA facility

Boral trials concrete with aggregates recarbonated via carbon capture

High-end heritage: expanded St Vincent's Private Hospital, Fitzroy

Revised 2025 edition of Australian Asthma Handbook now available

AdPha marks World Patient Safety Day with Medication Safety article series

Tas doctors "strongly oppose" any taxpayer-funded home birth scheme

Perich Centre for Robotics & Health Technology opens in Liverpool

Tyre recycling project addresses mining industry waste

How AI is empowering renewable energy in Australia

Australia's 2035 climate target announced

GECA–Rebuilt partnership to improve sustainability

Large-scale battery boom points to a cheaper power alternative

Lonza BioWhittaker UltraDoma PF protein-free hybridoma medium

Beckman Coulter Life Sciences IR820 and IR870 infrared dye antibody conjugates

AdipoGen Life Sciences PANoptosis research antibodies

Cytek 16-Color NK Cell Immunoprofiling Panel

Content from other channels on our network